{"id":"W3081207055","doi":"10.1016/s2152-2650(20)30443-2","title":"How the COG is Approaching the High-Risk Patient with ALL: Incorporation of Immunotherapy into Frontline Treatment","year":2020,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Blinatumomab; Medicine; Cog; Tolerability; Oncology; Chemotherapy; Immunotherapy; Internal medicine; Clinical trial; Refractory (planetary science); Calicheamicin; Intensive care medicine; Lymphoblastic Leukemia; Leukemia; Adverse effect; Cancer; Myeloid leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006884296,0.0006713441,0.0008588143,0.0008320616,0.003275293,0.009040322,0.001568755,0.005649106,0.004466446],"category_scores_gemma":[0.01673904,0.000440172,0.001033063,0.0004995812,0.003666173,0.006537921,0.005099745,0.01740134,0.002466712],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005503722,"about_ca_system_score_gemma":0.01364323,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007810684,"about_ca_topic_score_gemma":0.02117755,"domain_scores_codex":[0.9955568,0.002106777,0.0002296773,0.0003701339,0.0009358514,0.000800746],"domain_scores_gemma":[0.9924006,0.001868804,0.0004067549,0.0002714859,0.001291011,0.003761257],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006960398,0.0009614077,0.02344451,0.0006372317,0.0003570236,0.00192795,0.003308832,0.003408636,0.002134144,0.02957082,0.3363434,0.59721],"study_design_scores_gemma":[0.0003131314,0.001961465,0.01783148,0.002478102,0.0005164661,0.004895091,0.01114601,0.003113755,0.001995092,0.1575056,0.7980013,0.0002424237],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.02180941,0.01927344,0.00729173,0.9083083,0.006951659,0.0001095913,0.0001209557,0.0003626482,0.03577235],"genre_scores_gemma":[0.4461361,0.05389119,0.04637623,0.4140634,0.02193419,0.0003160403,0.0004354301,0.0006196313,0.01622792],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.009040322,"threshold_uncertainty_score":0.03993255,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04984465424495905,"score_gpt":0.3120130129867003,"score_spread":0.2621683587417413,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}